A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions
- PMID: 10547170
- DOI: 10.1001/archinte.159.19.2306
A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions
Abstract
Background: Hospital pharmacists make many recommendations that improve patients' quality of care and/or reduce drug costs. While the impact of quality-of-care interventions is difficult to quantify, those limited to cost savings could be assessed in a prospective, randomized fashion.
Objective: To assess the impact of pharmacist-initiated interventions on cost savings.
Methods: Six pharmacists at a large university hospital recorded patient-specific recommendations for 30 days. All quality-of-care interventions were completed by the pharmacists, but those strictly aimed at reducing costs were stratified by drug class and randomized to an intervention or control group. Pharmacists contacted physicians with cost-saving recommendations in the intervention group, while control group patients were simply observed.
Main outcome measure: Drug costs after randomization.
Results: Most (n=967 [79%]) of the 1226 interventions recorded were aimed at improving quality of care. The remaining 259 (21%) provided equivalent quality of care, but at less expense. These cost-saving interventions typically involved streamlining therapy to less expensive agents (39%), discontinuing an unnecessary medication (25%), or modifying the route of administration (24%). The group randomized to receive a pharmacist's intervention had drug costs that were 41% lower than those in the control group (mean, $73.75 vs $43.40; P<.001). Interventions involving anti-infective agents had the greatest cost savings (mean, $104.08 vs $58.45; P<.001). For our institution, this extrapolates to an annual savings of approximately $394,000 (95% confidence interval, $46,000-$742,000). As expected, these interventions had no impact on length of hospital stay, in-hospital mortality, 30-day readmissions, or the need to readminister the targeted medication or restart intravenous therapy.
Conclusions: While interventions solely aimed at reducing costs represent a small portion of a pharmacist's activities, they can result in significant savings for an institution.
Similar articles
-
Focus and impact of pharmacists' interventions.Can J Hosp Pharm. 1993 Jun;46(3):101-8. Can J Hosp Pharm. 1993. PMID: 10126864 Review.
-
Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic.Am J Hosp Pharm. 1992 Jul;49(7):1681-8. Am J Hosp Pharm. 1992. PMID: 1621723
-
A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals.Br J Clin Pharmacol. 2004 Apr;57(4):513-21. doi: 10.1046/j.1365-2125.2003.02029.x. Br J Clin Pharmacol. 2004. PMID: 15025751 Free PMC article.
-
Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: results from the North Carolina polypharmacy initiative.J Manag Care Pharm. 2005 Sep;11(7):575-83. doi: 10.18553/jmcp.2005.11.7.575. J Manag Care Pharm. 2005. PMID: 16137215 Free PMC article.
-
[Roles and impacts of pharmaceutical activity from 1990 to today: Literature review and research perspectives].Ann Pharm Fr. 2020 Jan;78(1):58-69. doi: 10.1016/j.pharma.2019.07.005. Epub 2019 Sep 26. Ann Pharm Fr. 2020. PMID: 31564419 Review. French.
Cited by
-
Optimizing Collaborative Care of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes: An Example Practice Model at a Health Care Practice in Kentucky, United States.Diabetes Ther. 2024 Jan;15(1):1-11. doi: 10.1007/s13300-023-01500-7. Epub 2023 Nov 2. Diabetes Ther. 2024. PMID: 37914833 Free PMC article.
-
Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.Res Social Adm Pharm. 2014 Jan-Feb;10(1):106-25. doi: 10.1016/j.sapharm.2013.03.007. Epub 2013 Jun 10. Res Social Adm Pharm. 2014. PMID: 23759673 Free PMC article.
-
How to increase return on investment of the intensive care pharmacist - fear of flying.Intensive Care Med. 2006 Apr;32(4):511-5. doi: 10.1007/s00134-006-0072-2. Epub 2006 Feb 16. Intensive Care Med. 2006. PMID: 16482393 No abstract available.
-
Selecting a clinical intervention documentation system for an academic setting.Am J Pharm Educ. 2011 Mar 10;75(2):37. doi: 10.5688/ajpe75237. Am J Pharm Educ. 2011. PMID: 21519426 Free PMC article. Review.
-
Use of a general level framework to facilitate performance improvement in hospital pharmacists in Singapore.Am J Pharm Educ. 2012 Aug 10;76(6):107. doi: 10.5688/ajpe766107. Am J Pharm Educ. 2012. PMID: 22919083 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials